Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases

Clinical Immunology

Volumn 138, Issue 3, 2011, Pages 247-254

  Di Pauli, Franziska ^a   Mader, Simone ^a   Rostasy, Kevin ^a   Schanda, Kathrin ^a   Bajer Kornek, Barbara ^b   Ehling, Rainer ^a   Deisenhammer, Florian ^a   Reindl, Markus ^a   Berger, Thomas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute disseminated encephalomyelitis; Autoantibodies; Cerebrospinal fluid; Clinically isolated syndrome; Multiple sclerosis; Myelin oligodendrocyte glycoprotein

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICALLY ISOLATED SYNDROME; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; YOUNG ADULT;

EID: 79851515866     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.11.013     Document Type: Article

References (33)

1. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 2005, 204:208-231.
2. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
3. Franciotta D., Salvetti M., Lolli F., Serafini B., Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008, 7:852-858.
4. McLaughlin K.A., Wucherpfennig K.W. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv. Immunol. 2008, 98:121-149.
5. Lassmann H., Bruck W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
6. Kabat E.A., Glusman M., Knaub V. Quantitative estimation of the albumin and gamma-globulin in normal and pathological cerebrospinal fluid by immunochemical methods. Am. J. Med. 1948, 4:653-662.
7. Freedman M.S., Thompson E.J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., Ohman S., Racke M.K., Sharief M., Sindic C.J., Sellebjerg F., Tourtellotte W.W. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 2005, 62:865-870.
8. Reindl M., Khalil M., Berger T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 2006, 180:50-62.
9. Brunner C., Lassmann H., Waehneldt T.V., Matthieu J.M., Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2', 3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J. Neurochem. 1989, 52:296-304.
10. Kerlero de Rosbo N., Honegger P., Lassmann H., Matthieu J.M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 1990, 55:583-587.
11. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 1988, 130:443-454.
12. Marta C.B., Oliver A.R., Sweet R.A., Pfeiffer S.E., Ruddle N.H. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl Acad. Sci. USA 2005, 102:13992-13997.
13. Lalive P.H., Menge T., Delarasse C., Della Gaspera B., Pham-Dinh D., Villoslada P., von Budingen H.C., Genain C.P. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:2280-2285.
14. Gaertner S., de Graaf K.L., Greve B., Weissert R. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 2004, 63:2381-2383.
15. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Bruck W., Hartung H.P., Stadelmann C., Hemmer B. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:19057-19062.
16. O'Connor K.C., McLaughlin K.A., De Jager P.L., Chitnis T., Bettelli E., Xu C., Robinson W.H., Cherry S.V., Bar-Or A., Banwell B., Fukaura H., Fukazawa T., Tenembaum S., Wong S.J., Tavakoli N.P., Idrissova Z., Viglietta V., Rostasy K., Pohl D., Dale R.C., Freedman M., Steinman L., Buckle G.J., Kuchroo V.K., Hafler D.A., Wucherpfennig K.W. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 2007, 13:211-217.
17. Brilot F., Dale R.C., Selter R.C., Grummel V., Kalluri S.R., Aslam M., Busch V., Zhou D., Cepok S., Hemmer B. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 2009, 66:833-842.
18. McLaughlin K.A., Chitnis T., Newcombe J., Franz B., Kennedy J., McArdel S., Kuhle J., Kappos L., Rostasy K., Pohl D., Gagne D., Ness J.M., Tenembaum S., O'Connor K.C., Viglietta V., Wong S.J., Tavakoli N.P., de Seze J., Idrissova Z., Khoury S.J., Bar-Or A., Hafler D.A., Banwell B., Wucherpfennig K.W. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 2009, 183:4067-4076.
19. Young N.P., Weinshenker B.G., Lucchinetti C.F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 2008, 28:84-94.
20. Rust R.S. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin. Pediatr. Neurol. 2000, 7:66-90.
21. Krupp L.B., Banwell B., Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68:S7-S12.
22. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
23. Pittock S.J., Reindl M., Achenbach S., Berger T., Bruck W., Konig F., Morales Y., Lassmann H., Bryant S., Moore S.B., Keegan B.M., Lucchinetti C.F. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult. Scler. 2007, 13:7-16.
24. Wang H., Munger K.L., Reindl M., O'Reilly E.J., Levin L.I., Berger T., Ascherio A. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008, 71:1142-1146.
25. Yeh E.A., Chitnis T., Krupp L., Ness J., Chabas D., Kuntz N., Waubant E. Pediatric multiple sclerosis. Nat. Rev. Neurol. 2009, 5:621-631.
26. Young N.P., Weinshenker B.G., Parisi J.E., Scheithauer B., Giannini C., Roemer S.F., Thomsen K.M., Mandrekar J.N., Erickson B.J., Lucchinetti C.F. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010, 133(PT 2):333-348.
27. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999, 122(Pt 11):2047-2056.
28. Jarius S., Franciotta D., Paul F., Ruprecht K., Bergamaschi R., Rommer P.S., Reuss R., Probst C., Kristoferitsch W., Wandinger K.P., Wildemann B. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J. Neuroinflammation 2010, 7:52.
29. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., Watanabe S., Shiga Y., Kanaoka C., Fujimori J., Sato S., Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1224-1234.
30. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224-1231.
31. Marchioni E., Ravaglia S., Piccolo G., Furione M., Zardini E., Franciotta D., Alfonsi E., Minoli L., Romani A., Todeschini A., Uggetti C., Tavazzi E., Ceroni M. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005, 65:1057-1065.
32. Ravaglia S., Piccolo G., Ceroni M., Franciotta D., Pichiecchio A., Bastianello S., Tavazzi E., Minoli L., Marchioni E. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J. Neurol. 2007, 254:1518-1523.
33. Khurana D.S., Melvin J.J., Kothare S.V., Valencia I., Hardison H.H., Yum S., Faerber E.N., Legido A. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005, 116:431-436.